DOXORUBICIN

DOXORUBICIN was reported 90405 times

DOXORUBICIN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 DESMOPLASTIC SMALL ROUND CELL TUMOUR 47 0.5402
1 DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT 1181 0.5351
2 B-CELL LYMPHOMA REFRACTORY 44 0.4944
3 FOLLICULAR LYMPHOMA RECURRENT 37 0.4625
4 B-CELL LYMPHOMA RECURRENT 246 0.4530
5 DIFFUSE LARGE B-CELL LYMPHOMA REFRACTORY 364 0.3844
6 MANTLE CELL LYMPHOMA RECURRENT 147 0.3379
7 FOLLICULAR LYMPHOMA 242 0.2750
8 REFRACTORY CANCER 55 0.2570
9 HIGH-GRADE B-CELL LYMPHOMA 48 0.2567
10 LYMPHOMA TRANSFORMATION 92 0.2556
11 CENTRAL HYPOTHYROIDISM 77 0.2326
12 MENINGITIS TUBERCULOUS 121 0.2165
13 DIFFUSE LARGE B-CELL LYMPHOMA STAGE IV 70 0.2134
14 HEPATITIS B REACTIVATION 609 0.1917
15 NEUTROPENIC INFECTION 179 0.1870
16 ANAPLASTIC LARGE-CELL LYMPHOMA 39 0.1653
17 REMISSION NOT ACHIEVED 102 0.1640
18 DIFFUSE LARGE B-CELL LYMPHOMA 1248 0.1618
19 TOXIC CARDIOMYOPATHY 36 0.1607
20 MYELOID LEUKAEMIA 77 0.1537
21 PLASMABLASTIC LYMPHOMA 55 0.1536
22 ANAPLASTIC LARGE CELL LYMPHOMA T- AND NULL-CELL TYPES 45 0.1536
23 OVARIAN FAILURE 82 0.1533
24 OSTEOSARCOMA 55 0.1429
25 CARDIOTOXICITY 1271 0.1423
26 CONGENITAL APLASIA 44 0.1415
27 FEBRILE NEUTROPENIA 9348 0.1408
28 CENTRAL NERVOUS SYSTEM LYMPHOMA 194 0.1407
29 PERIPHERAL T-CELL LYMPHOMA UNSPECIFIED 80 0.1349
30 HUMORAL IMMUNE DEFECT 48 0.1294
31 HAEMATOTOXICITY 1210 0.1272
32 TISSUE INFILTRATION 36 0.1220
33 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOMA 72 0.1218
34 SMOOTH MUSCLE CELL NEOPLASM 48 0.1148
35 MALIGNANT TRANSFORMATION 51 0.1136
36 ACQUIRED GENE MUTATION 145 0.1106
37 PLASMA CELL LEUKAEMIA 66 0.1100
38 AZOOSPERMIA 42 0.1094
39 HER2 POSITIVE BREAST CANCER 41 0.1093
40 COMPUTERISED TOMOGRAM THORAX ABNORMAL 75 0.1092
41 NEUTROPENIC COLITIS 219 0.1058
42 NEUROBLASTOMA 39 0.1018
43 DILATED CARDIOMYOPATHY 100 0.0989
44 PSEUDOMONAL BACTERAEMIA 84 0.0984
45 FEBRILE BONE MARROW APLASIA 416 0.0978
46 CYTOMEGALOVIRUS CHORIORETINITIS 187 0.0958
47 TUMOUR LYSIS SYNDROME 835 0.0948
48 NEUTROPENIC SEPSIS 658 0.0920
49 PLASMA CELL MYELOMA REFRACTORY 121 0.0904
50 HEPATITIS B 543 0.0900
51 LEFT VENTRICULAR DILATATION 46 0.0900
52 SALIVARY GLAND CANCER 44 0.0892
53 SECOND PRIMARY MALIGNANCY 726 0.0872
54 METASTASES TO BONE MARROW 43 0.0860
55 ANGIOCENTRIC LYMPHOMA 42 0.0854
56 MANTLE CELL LYMPHOMA 130 0.0854
57 ACUTE MYELOID LEUKAEMIA 1325 0.0849
58 B-CELL TYPE ACUTE LEUKAEMIA 61 0.0831
59 HEART FAILURE WITH REDUCED EJECTION FRACTION 44 0.0822
60 MYELODYSPLASTIC SYNDROME 1189 0.0821
61 PERIPHERAL MOTOR NEUROPATHY 115 0.0820
62 ANAL INFLAMMATION 51 0.0798
63 MUCOSAL INFLAMMATION 2091 0.0798
64 SECONDARY IMMUNODEFICIENCY 95 0.0782
65 VENTRICULAR DYSFUNCTION 200 0.0770
66 ENTEROCOCCAL BACTERAEMIA 78 0.0736
67 PERIPHERAL SENSORY NEUROPATHY 428 0.0731
68 KLEBSIELLA SEPSIS 79 0.0701
69 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 355 0.0697
70 PNEUMOCYSTIS JIROVECII INFECTION 83 0.0695
71 SYSTEMIC CANDIDA 173 0.0688
72 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 174 0.0674
73 METASTASES TO SKIN 69 0.0668
74 STAPHYLOCOCCAL BACTERAEMIA 290 0.0667
75 HYPOGAMMAGLOBULINAEMIA 438 0.0666
76 CYTOPENIA 809 0.0660
77 BONE MARROW TOXICITY 78 0.0658
78 JC VIRUS INFECTION 105 0.0656
79 VIRAL HAEMORRHAGIC CYSTITIS 46 0.0646
80 PNEUMOCYSTIS JIROVECII PNEUMONIA 645 0.0642
81 THERAPY PARTIAL RESPONDER 1001 0.0641
82 MYELOPATHY 121 0.0637
83 LEFT VENTRICULAR DYSFUNCTION 424 0.0632
84 VENOOCCLUSIVE DISEASE 158 0.0630
85 SARS-COV-2 TEST NEGATIVE 42 0.0622
86 NEOPLASM RECURRENCE 209 0.0616
87 VASOGENIC CEREBRAL OEDEMA 44 0.0611
88 ADMINISTRATION SITE EXTRAVASATION 61 0.0611
89 GLIOMA 39 0.0607
90 ACUTE PROMYELOCYTIC LEUKAEMIA 62 0.0603
91 PSYCHOLOGICAL TRAUMA 520 0.0602
92 CEREBRAL ASPERGILLOSIS 37 0.0602
93 ENTEROCOCCAL SEPSIS 48 0.0593
94 GENE MUTATION 117 0.0591
95 INFECTION REACTIVATION 67 0.0585
96 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 481 0.0583
97 PSEUDOMONAL SEPSIS 102 0.0582
98 GASTROINTESTINAL TOXICITY 277 0.0576
99 ESCHERICHIA BACTERAEMIA 135 0.0574
100 DEVICE RELATED THROMBOSIS 56 0.0568
101 B-CELL LYMPHOMA 192 0.0565
102 DISEASE PROGRESSION 6616 0.0559
103 CYTOKINE RELEASE SYNDROME 1107 0.0551
104 SYSTOLIC DYSFUNCTION 58 0.0550
105 TRANSFORMATION TO ACUTE MYELOID LEUKAEMIA 36 0.0549
106 APLASIA 107 0.0546
107 MYELOPROLIFERATIVE NEOPLASM 36 0.0543
108 ENTEROVIRUS INFECTION 46 0.0532
109 CYSTITIS HAEMORRHAGIC 211 0.0523
110 GLIOBLASTOMA MULTIFORME 44 0.0523
111 PNEUMONIA RESPIRATORY SYNCYTIAL VIRAL 44 0.0522
112 PNEUMONIA KLEBSIELLA 96 0.0522
113 VENOOCCLUSIVE LIVER DISEASE 255 0.0516
114 T-CELL LYMPHOMA 59 0.0515
115 CEREBRAL TOXOPLASMOSIS 48 0.0514
116 CARDIOMYOPATHY 755 0.0510
117 SUBCLAVIAN VEIN THROMBOSIS 58 0.0509
118 PERIPHERAL SENSORIMOTOR NEUROPATHY 64 0.0509
119 PREMATURE MENOPAUSE 47 0.0509
120 ASPERGILLUS INFECTION 334 0.0508
121 ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION 47 0.0508
122 CARDIAC DYSFUNCTION 189 0.0507
123 STRONGYLOIDIASIS 81 0.0501
124 BONE MARROW DISORDER 150 0.0496
125 FANCONI SYNDROME 70 0.0495
126 ESCHERICHIA SEPSIS 143 0.0493
127 CANDIDA SEPSIS 44 0.0491
128 IMMUNE-MEDIATED MYOCARDITIS 79 0.0489
129 CYTOMEGALOVIRUS INFECTION REACTIVATION 216 0.0488
130 NEUTROPENIA 6563 0.0482
131 EJECTION FRACTION DECREASED 749 0.0481
132 STREPTOCOCCAL BACTERAEMIA 52 0.0478
133 KLEBSIELLA BACTERAEMIA 45 0.0474
134 SYSTEMIC MYCOSIS 55 0.0471
135 BONE MARROW FAILURE 949 0.0467
136 ACUTE LYMPHOCYTIC LEUKAEMIA 132 0.0466
137 VACCINATION FAILURE 77 0.0463
138 HEPATITIS E 73 0.0462
139 FEBRILE INFECTION 54 0.0459
140 BLOOD LACTATE DEHYDROGENASE INCREASED 723 0.0456
141 EPSTEIN-BARR VIRUS INFECTION 285 0.0456
142 PNEUMONIA FUNGAL 177 0.0448
143 ENTEROCOLITIS INFECTIOUS 41 0.0444
144 DRUG CLEARANCE DECREASED 58 0.0444
145 CYTOGENETIC ABNORMALITY 50 0.0443
146 DYSPLASIA 53 0.0442
147 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 168 0.0439
148 STREPTOCOCCAL SEPSIS 52 0.0438
149 KLEBSIELLA INFECTION 221 0.0437
150 HYPOFIBRINOGENAEMIA 43 0.0433
151 MYELOSUPPRESSION 1557 0.0432
152 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 254 0.0428
153 BRONCHOPULMONARY ASPERGILLOSIS 329 0.0424
154 SMALL INTESTINAL PERFORATION 79 0.0421
155 EPSTEIN-BARR VIRUS INFECTION REACTIVATION 55 0.0418
156 ABDOMINAL LYMPHADENOPATHY 36 0.0415
157 PANCYTOPENIA 2299 0.0411
158 TRANSITIONAL CELL CARCINOMA 53 0.0408
159 TROPONIN I INCREASED 68 0.0408
160 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 306 0.0407
161 TUMOUR NECROSIS 43 0.0407
162 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 388 0.0406
163 METASTASES TO MENINGES 92 0.0404
164 PULMONARY TOXICITY 285 0.0403
165 TOXOPLASMOSIS 43 0.0398
166 ALVEOLITIS 56 0.0396
167 OTOTOXICITY 73 0.0394
168 VARICELLA ZOSTER VIRUS INFECTION 81 0.0390
169 BACTERIAL SEPSIS 127 0.0390
170 PLASMACYTOMA 71 0.0381
171 SEPTIC SHOCK 1644 0.0377
172 FUNGAEMIA 59 0.0375
173 VENA CAVA THROMBOSIS 62 0.0373
174 TRAUMATIC LUNG INJURY 72 0.0372
175 METASTASES TO PERITONEUM 94 0.0372
176 POLYNEUROPATHY 444 0.0370
177 SOFT TISSUE INFECTION 67 0.0366
178 SARCOMA 41 0.0362
179 OVARIAN CANCER RECURRENT 58 0.0361
180 LEUKAEMIA RECURRENT 61 0.0361
181 PNEUMONIA CYTOMEGALOVIRAL 70 0.0360
182 NEUTROPHIL COUNT ABNORMAL 101 0.0357
183 LEUKOPENIA 1787 0.0357
184 OSTEOLYSIS 73 0.0357
185 VENOUS THROMBOSIS 140 0.0356
186 BACTERAEMIA 422 0.0355
187 PARAINFLUENZAE VIRUS INFECTION 54 0.0355
188 INVASIVE DUCTAL BREAST CARCINOMA 96 0.0353
189 BLOOD BILIRUBIN ABNORMAL 45 0.0351
190 BREAST CANCER RECURRENT 111 0.0351
191 NEUROTOXICITY 615 0.0351
192 MUCORMYCOSIS 91 0.0350
193 THROMBOCYTOPENIA 3886 0.0347
194 BLOOD CULTURE POSITIVE 104 0.0347
195 VENTRICULAR HYPOKINESIA 111 0.0345
196 LYMPHOPENIA 487 0.0344
197 MENINGITIS CRYPTOCOCCAL 60 0.0343
198 STAPHYLOCOCCAL SEPSIS 168 0.0340
199 NEPHROPATHY TOXIC 381 0.0339
200 GRANULOCYTE COUNT DECREASED 62 0.0334
201 EPSTEIN-BARR VIRAEMIA 37 0.0334
202 NEUTROPHIL COUNT DECREASED 1350 0.0331
203 ENTEROCOCCAL INFECTION 160 0.0331
204 TROPONIN T INCREASED 41 0.0323
205 LYMPHADENITIS 78 0.0322
206 LYMPHOMA 495 0.0320
207 METASTASES TO LYMPH NODES 216 0.0320
208 CONGESTIVE CARDIOMYOPATHY 133 0.0319
209 HYPOALBUMINAEMIA 243 0.0312
210 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 55 0.0311
211 ORGANISING PNEUMONIA 153 0.0308
212 BK VIRUS INFECTION 104 0.0308
213 HISTIOCYTOSIS HAEMATOPHAGIC 91 0.0306
214 NEOPLASM PROGRESSION 1062 0.0305
215 CLOSTRIDIUM DIFFICILE COLITIS 323 0.0304
216 JUGULAR VEIN THROMBOSIS 54 0.0303
217 PLATELET TRANSFUSION 39 0.0303
218 METASTASIS 216 0.0302
219 B-LYMPHOCYTE COUNT DECREASED 41 0.0301
220 HERPES SIMPLEX 194 0.0298
221 EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED 37 0.0297
222 CLOSTRIDIUM COLITIS 36 0.0297
223 MULTIPLE ORGAN DYSFUNCTION SYNDROME 840 0.0296
224 METASTASES TO LUNG 338 0.0292
225 STEM CELL TRANSPLANT 73 0.0292
226 MYELITIS 45 0.0290
227 TROPONIN INCREASED 220 0.0289
228 ACUTE HEPATIC FAILURE 395 0.0289
229 PNEUMATOSIS INTESTINALIS 82 0.0287
230 SKIN TOXICITY 162 0.0286
231 OLIGOHYDRAMNIOS 94 0.0282
232 FOETAL GROWTH RESTRICTION 171 0.0281
233 DEVICE RELATED SEPSIS 56 0.0278
234 COVID-19 PNEUMONIA 328 0.0278
235 EMBOLISM 229 0.0275
236 AGRANULOCYTOSIS 511 0.0275
237 PNEUMONIA PSEUDOMONAL 42 0.0274
238 DIASTOLIC DYSFUNCTION 84 0.0272
239 CYTOMEGALOVIRUS INFECTION 452 0.0272
240 PSEUDOMONAS INFECTION 233 0.0271
241 HYPERTRIGLYCERIDAEMIA 159 0.0271
242 OESOPHAGEAL CANDIDIASIS 108 0.0271
243 LEFT VENTRICULAR FAILURE 93 0.0270
244 LYMPHOCYTOSIS 58 0.0269
245 PARAPARESIS 48 0.0269
246 LYMPHADENOPATHY MEDIASTINAL 51 0.0266
247 CYTOMEGALOVIRUS VIRAEMIA 118 0.0265
248 HEPATOSPLENOMEGALY 68 0.0265
249 ENTEROCOLITIS 151 0.0261
250 PNEUMOPERITONEUM 48 0.0260
251 ADENOVIRUS INFECTION 75 0.0258
252 LUNG OPACITY 68 0.0258
253 ESCHERICHIA INFECTION 212 0.0257
254 CANDIDA INFECTION 435 0.0257
255 SEPSIS 2871 0.0257
256 ASPARTATE AMINOTRANSFERASE ABNORMAL 39 0.0256
257 CLOSTRIDIUM TEST POSITIVE 56 0.0254
258 QUADRIPLEGIA 52 0.0252
259 INTESTINAL PERFORATION 283 0.0252
260 CRYPTOCOCCOSIS 41 0.0251
261 CAPILLARY LEAK SYNDROME 52 0.0251
262 HYPERTRANSAMINASAEMIA 173 0.0248
263 LEUKOENCEPHALOPATHY 92 0.0247
264 NEUROLOGICAL DECOMPENSATION 57 0.0246
265 GASTRIC PERFORATION 67 0.0246
266 PNEUMONITIS 660 0.0242
267 PNEUMONIA VIRAL 77 0.0241
268 ATELECTASIS 232 0.0240
269 METASTASES TO BONE 394 0.0240
270 CYTOMEGALOVIRUS COLITIS 55 0.0239
271 CARDIAC FAILURE ACUTE 159 0.0238
272 HYPERURICAEMIA 98 0.0238
273 BREAST CANCER METASTATIC 255 0.0237
274 RHINOVIRUS INFECTION 91 0.0234
275 ALANINE AMINOTRANSFERASE ABNORMAL 49 0.0232
276 NEUROPATHY PERIPHERAL 2187 0.0230
277 LYMPHOPROLIFERATIVE DISORDER 67 0.0228
278 OPPORTUNISTIC INFECTION 42 0.0227
279 METASTASES TO SPINE 76 0.0226
280 MALIGNANT PLEURAL EFFUSION 38 0.0225
281 HEPATOTOXICITY 497 0.0223
282 LYMPHADENOPATHY 787 0.0222
283 MALIGNANT NEOPLASM PROGRESSION 2275 0.0222
284 GRAFT VERSUS HOST DISEASE 159 0.0221
285 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 47 0.0221
286 ILEUS PARALYTIC 98 0.0219
287 APLASTIC ANAEMIA 114 0.0218
288 HYPOPHOSPHATAEMIA 161 0.0218
289 EMBOLISM VENOUS 66 0.0217
290 LUNG INFILTRATION 192 0.0217
291 CHRONIC LYMPHOCYTIC LEUKAEMIA 102 0.0215
292 INTERSTITIAL LUNG DISEASE 1041 0.0215
293 DISEASE RECURRENCE 1022 0.0215
294 BONE LESION 77 0.0213
295 HEPATORENAL SYNDROME 36 0.0213
296 RECURRENT CANCER 87 0.0213
297 HUMAN HERPESVIRUS 6 INFECTION 40 0.0211
298 HYPOPROTEINAEMIA 40 0.0211
299 BRAIN ABSCESS 53 0.0209
300 CACHEXIA 107 0.0208
301 HEPATIC FIBROSIS 71 0.0207
302 METASTASES TO LIVER 363 0.0206
303 HYPERPHOSPHATAEMIA 44 0.0204
304 MONOPARESIS 37 0.0204
305 ANAEMIA 3892 0.0204
306 HYPERBILIRUBINAEMIA 211 0.0203
307 PLASMA CELL MYELOMA 785 0.0201
308 CEREBELLAR SYNDROME 44 0.0201
309 PLASMA CELL MYELOMA RECURRENT 65 0.0200
310 ILEUS 246 0.0198
311 PNEUMOCYSTIS JIROVECI PNEUMONIA 44 0.0197
312 DRUG RESISTANCE 506 0.0197
313 LUNG ADENOCARCINOMA 59 0.0196
314 HAEMOGLOBIN ABNORMAL 126 0.0196
315 DYSAESTHESIA 60 0.0196
316 CARDIAC FAILURE CHRONIC 83 0.0195
317 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 451 0.0193
318 ACUTE RESPIRATORY DISTRESS SYNDROME 337 0.0190
319 HEPATIC LESION 82 0.0189
320 SUSPECTED OFF LABEL USE 85 0.0188
321 ADRENAL INSUFFICIENCY 226 0.0186
322 GASTROINTESTINAL PERFORATION 75 0.0180
323 THROMBOTIC MICROANGIOPATHY 175 0.0179
324 GASTROINTESTINAL NECROSIS 52 0.0178
325 HYPOKALAEMIA 823 0.0178
326 HYPERVOLAEMIA 88 0.0178
327 SMALL INTESTINAL OBSTRUCTION 217 0.0176
328 METASTASES TO CENTRAL NERVOUS SYSTEM 224 0.0173
329 ACUTE PULMONARY OEDEMA 97 0.0173
330 RESPIRATORY FAILURE 1259 0.0172
331 STOMATITIS 1040 0.0171
332 EXTRAVASATION 70 0.0170
333 LYMPHOCYTE COUNT DECREASED 300 0.0170
334 ESCHERICHIA URINARY TRACT INFECTION 72 0.0169
335 ASCITES 497 0.0169
336 STREPTOCOCCAL INFECTION 94 0.0169
337 PNEUMONIA BACTERIAL 154 0.0168
338 PULMONARY ALVEOLAR HAEMORRHAGE 94 0.0167
339 IMMUNOSUPPRESSION 147 0.0166
340 PARAPLEGIA 48 0.0166
341 FIBROSIS 51 0.0166
342 VASCULAR DEVICE INFECTION 75 0.0165
343 THERAPY NON-RESPONDER 742 0.0165
344 WHITE BLOOD CELL DISORDER 44 0.0164
345 ELECTROLYTE IMBALANCE 191 0.0164
346 ABDOMINAL MASS 44 0.0164
347 GRAFT VERSUS HOST DISEASE IN SKIN 36 0.0163
348 GRANULOCYTOPENIA 92 0.0161
349 TUMOUR HAEMORRHAGE 46 0.0161
350 DEVICE RELATED INFECTION 247 0.0160
351 LIVER ABSCESS 52 0.0160
352 NEOPLASM 184 0.0160
353 PLEURAL EFFUSION 967 0.0159
354 PORTAL HYPERTENSION 49 0.0159
355 RESPIRATORY SYNCYTIAL VIRUS INFECTION 138 0.0158
356 CARDIAC FAILURE 1270 0.0158
357 SPLENOMEGALY 185 0.0158
358 HEPATIC FAILURE 476 0.0158
359 LUNG CONSOLIDATION 44 0.0157
360 THROMBOPHLEBITIS 55 0.0157
361 HYDRONEPHROSIS 117 0.0156
362 HYPERPYREXIA 66 0.0156
363 PLATELET DISORDER 39 0.0155
364 HYPOXIA 544 0.0154
365 PREMATURE BABY 463 0.0154
366 BACTERIAL INFECTION 286 0.0153
367 INFECTION 2211 0.0153
368 NEUROLOGICAL SYMPTOM 87 0.0152
369 PARONYCHIA 66 0.0150
370 MYOCARDITIS 172 0.0150
371 CARDIAC TAMPONADE 71 0.0149
372 RENAL TUBULAR DISORDER 42 0.0149
373 ENCEPHALITIS 103 0.0149
374 ENTERITIS 95 0.0148
375 CARDIOGENIC SHOCK 211 0.0147
376 PERFORMANCE STATUS DECREASED 68 0.0146
377 MALNUTRITION 163 0.0146
378 SINUS TACHYCARDIA 206 0.0145
379 HEPATITIS FULMINANT 43 0.0145
380 TACHYARRHYTHMIA 36 0.0144
381 CLOSTRIDIUM DIFFICILE INFECTION 314 0.0144
382 ENCEPHALOPATHY 351 0.0143
383 METABOLIC DISORDER 83 0.0143
384 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 38 0.0143
385 MENINGITIS ASEPTIC 64 0.0142
386 LUNG INFECTION 219 0.0141
387 ENDOCARDITIS 72 0.0140
388 RED CELL DISTRIBUTION WIDTH INCREASED 58 0.0139
389 NON-CARDIAC CHEST PAIN 44 0.0139
390 PREMATURE DELIVERY 221 0.0139
391 NEUTROPHIL COUNT INCREASED 142 0.0139
392 TRANSAMINASES INCREASED 308 0.0138
393 TOXIC ENCEPHALOPATHY 70 0.0138
394 WHITE BLOOD CELL COUNT DECREASED 1496 0.0138
395 IMPAIRED QUALITY OF LIFE 198 0.0138
396 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 140 0.0136
397 LOW BIRTH WEIGHT BABY 108 0.0136
398 HYPOMAGNESAEMIA 189 0.0136
399 DISSEMINATED INTRAVASCULAR COAGULATION 190 0.0135
400 NECROSIS 75 0.0135
401 AUTOIMMUNE HAEMOLYTIC ANAEMIA 46 0.0134
402 NECROTISING FASCIITIS 47 0.0133
403 CLOSTRIDIAL INFECTION 45 0.0133
404 FAILURE TO THRIVE 69 0.0133
405 ODYNOPHAGIA 79 0.0132
406 ACUTE RESPIRATORY FAILURE 254 0.0132
407 WHITE BLOOD CELL COUNT ABNORMAL 84 0.0131
408 ORAL FUNGAL INFECTION 36 0.0131
409 PROCTALGIA 84 0.0131
410 HERPES VIRUS INFECTION 75 0.0130
411 METASTATIC NEOPLASM 56 0.0130
412 COAGULOPATHY 216 0.0130
413 PREMATURE LABOUR 73 0.0129
414 TACHYPNOEA 175 0.0129
415 HAIR DISORDER 105 0.0127
416 PERICARDIAL EFFUSION 294 0.0127
417 HYPERCALCAEMIA 157 0.0127
418 CHEMOTHERAPY 48 0.0127
419 COLITIS 481 0.0127
420 CEREBRAL ISCHAEMIA 65 0.0126
421 PLATELET COUNT DECREASED 1343 0.0126
422 ABDOMINAL TENDERNESS 62 0.0125
423 MITRAL VALVE INCOMPETENCE 141 0.0124
424 ACUTE GRAFT VERSUS HOST DISEASE 57 0.0124
425 OESOPHAGITIS 136 0.0124
426 LYMPHOEDEMA 86 0.0124
427 SKIN INFECTION 139 0.0124
428 ATYPICAL PNEUMONIA 37 0.0124
429 ORTHOPNOEA 39 0.0122
430 ABDOMINAL ABSCESS 54 0.0122
431 GUILLAIN-BARRE SYNDROME 59 0.0122
432 CHRONIC GRAFT VERSUS HOST DISEASE 44 0.0122
433 FACIAL PARESIS 43 0.0121
434 PRODUCT USE IN UNAPPROVED INDICATION 3006 0.0121
435 UROSEPSIS 111 0.0120
436 PATHOLOGICAL FRACTURE 61 0.0120
437 PULMONARY HAEMORRHAGE 94 0.0120
438 HEART RATE ABNORMAL 67 0.0120
439 ORAL CANDIDIASIS 158 0.0120
440 PYREXIA 4149 0.0120
441 BLOOD DISORDER 96 0.0120
442 CHRONIC MYELOID LEUKAEMIA 55 0.0119
443 HYPOCALCAEMIA 225 0.0119
444 MASS 165 0.0118
445 IMMUNE THROMBOCYTOPENIA 54 0.0118
446 SARCOIDOSIS 56 0.0118
447 LEUKAEMIA 111 0.0118
448 STRESS CARDIOMYOPATHY 68 0.0117
449 LARGE INTESTINE PERFORATION 81 0.0117
450 AMYLASE INCREASED 43 0.0116
451 DEEP VEIN THROMBOSIS 752 0.0116
452 DEAFNESS NEUROSENSORY 38 0.0115
453 HYPERGLYCAEMIA 421 0.0115
454 ARTHRITIS BACTERIAL 47 0.0114
455 PNEUMOTHORAX 180 0.0113
456 PATHOGEN RESISTANCE 103 0.0113
457 INFLAMMATORY MARKER INCREASED 56 0.0113
458 HYPOVOLAEMIA 66 0.0113
459 HAIR COLOUR CHANGES 139 0.0112
460 BLOOD BILIRUBIN INCREASED 301 0.0111
461 STAPHYLOCOCCAL INFECTION 367 0.0111
462 HAEMODYNAMIC INSTABILITY 84 0.0110
463 MONOCYTE COUNT INCREASED 39 0.0107
464 OVARIAN CANCER 99 0.0107
465 HYPONATRAEMIA 603 0.0107
466 BRAIN OEDEMA 135 0.0107
467 CARDIOPULMONARY FAILURE 41 0.0105
468 OFF LABEL USE 9066 0.0103
469 MADAROSIS 119 0.0102
470 BLOOD LACTIC ACID INCREASED 54 0.0102
471 HYPERNATRAEMIA 51 0.0102
472 FOETAL DEATH 53 0.0102
473 C-REACTIVE PROTEIN INCREASED 370 0.0102
474 ALANINE AMINOTRANSFERASE INCREASED 624 0.0102
475 ASPARTATE AMINOTRANSFERASE INCREASED 538 0.0101
476 HEPATIC CYTOLYSIS 129 0.0101
477 BONE PAIN 591 0.0101
478 SHOCK HAEMORRHAGIC 82 0.0101
479 PULMONARY EMBOLISM 957 0.0101
480 PULMONARY TUBERCULOSIS 43 0.0101
481 CATHETER SITE INFECTION 38 0.0100
482 RESPIRATORY DISTRESS 277 0.0100
483 PULMONARY MASS 148 0.0099
484 ATRIAL FLUTTER 79 0.0099
485 LEUKOCYTOSIS 179 0.0099
486 HEPATOMEGALY 97 0.0099
487 BLOOD MAGNESIUM DECREASED 85 0.0098
488 PHLEBITIS 50 0.0098
489 HAEMORRHAGE INTRACRANIAL 143 0.0096
490 ERYSIPELAS 48 0.0095
491 HAIR TEXTURE ABNORMAL 127 0.0095
492 SKIN NECROSIS 49 0.0094
493 RESPIRATORY TRACT INFECTION 246 0.0094
494 PLATELET COUNT ABNORMAL 57 0.0094
495 ACUTE KIDNEY INJURY 1436 0.0094
496 HEPATIC FUNCTION ABNORMAL 349 0.0093
497 HEPATIC ENCEPHALOPATHY 87 0.0093
498 ANAL ABSCESS 50 0.0093
499 DERMATITIS BULLOUS 67 0.0092
500 BUNDLE BRANCH BLOCK LEFT 39 0.0092
501 HYPOVOLAEMIC SHOCK 44 0.0092
502 ISCHAEMIA 42 0.0091
503 PNEUMONIA 2940 0.0091
504 GENERAL PHYSICAL HEALTH DETERIORATION 1042 0.0090
505 BLOOD URIC ACID INCREASED 52 0.0090
506 CHOLECYSTITIS ACUTE 51 0.0090
507 MENINGITIS 60 0.0090
508 ACUTE CORONARY SYNDROME 74 0.0089
509 HEPATITIS 228 0.0089
510 LUNG NEOPLASM 38 0.0089
511 COMPRESSION FRACTURE 47 0.0088
512 MULTI-ORGAN FAILURE 151 0.0087
513 RETINAL HAEMORRHAGE 62 0.0087
514 LIPASE INCREASED 66 0.0086
515 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 472 0.0086
516 PLEURISY 51 0.0086
517 RENAL CYST 68 0.0086
518 FUNGAL INFECTION 284 0.0085
519 HYPOPHAGIA 217 0.0085
520 INTRACRANIAL PRESSURE INCREASED 47 0.0084
521 PANCREATITIS ACUTE 189 0.0084
522 GASTROENTERITIS 122 0.0084
523 APPENDICITIS 78 0.0083
524 CHOLESTASIS 160 0.0083
525 TOXICITY TO VARIOUS AGENTS 1402 0.0083
526 MONOPLEGIA 36 0.0083
527 NERVOUS SYSTEM DISORDER 258 0.0083
528 BODY TEMPERATURE INCREASED 168 0.0082
529 INFUSION RELATED REACTION 545 0.0082
530 INGUINAL HERNIA 50 0.0082
531 PAPILLOEDEMA 37 0.0082
532 TRICUSPID VALVE INCOMPETENCE 65 0.0082
533 HYDROCEPHALUS 44 0.0081
534 SMALL FOR DATES BABY 40 0.0080
535 ORAL DISORDER 59 0.0080
536 ALOPECIA 1577 0.0080
537 PERONEAL NERVE PALSY 45 0.0079
538 HERPES ZOSTER 455 0.0079
539 END STAGE RENAL DISEASE 144 0.0079
540 ATRIAL FIBRILLATION 766 0.0079
541 LOWER GASTROINTESTINAL HAEMORRHAGE 58 0.0078
542 SUPRAVENTRICULAR TACHYCARDIA 75 0.0078
543 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 39 0.0078
544 BLOOD ALBUMIN DECREASED 62 0.0078
545 CHOLECYSTITIS 93 0.0078
546 GAMMA-GLUTAMYLTRANSFERASE INCREASED 173 0.0078
547 COVID-19 1340 0.0076
548 HYPERAMMONAEMIA 38 0.0076
549 INTENTIONAL PRODUCT USE ISSUE 664 0.0076
550 TUBULOINTERSTITIAL NEPHRITIS 142 0.0076
551 OLIGURIA 47 0.0076
552 HEPATOCELLULAR CARCINOMA 57 0.0075
553 SKIN MASS 50 0.0075
554 ACIDOSIS 57 0.0075
555 DRUG-INDUCED LIVER INJURY 234 0.0075
556 IMMUNODEFICIENCY 111 0.0074
557 FOETAL EXPOSURE DURING PREGNANCY 599 0.0074
558 RENAL CELL CARCINOMA 36 0.0074
559 MYOSITIS 66 0.0073
560 PULMONARY FIBROSIS 141 0.0073
561 PRODUCT USE ISSUE 1369 0.0073
562 UPPER GASTROINTESTINAL HAEMORRHAGE 122 0.0072
563 HYPOTHYROIDISM 230 0.0072
564 ARRHYTHMIA 339 0.0072
565 TREATMENT FAILURE 592 0.0071
566 SPINAL PAIN 83 0.0071
567 HAEMOGLOBIN DECREASED 723 0.0070
568 HEMIPARESIS 119 0.0070
569 TACHYCARDIA 623 0.0070
570 LIVER INJURY 172 0.0070
571 VARICOSE VEIN 36 0.0070
572 GASTROINTESTINAL INFECTION 62 0.0069
573 OSTEONECROSIS 226 0.0069
574 ACUTE MYOCARDIAL INFARCTION 202 0.0068
575 HAEMATOCRIT DECREASED 135 0.0068
576 HEPATITIS C 82 0.0068
577 ANGINA UNSTABLE 44 0.0068
578 MOUTH ULCERATION 142 0.0067
579 SHOCK 154 0.0067
580 VENTRICULAR EXTRASYSTOLES 69 0.0066
581 SKIN LESION 182 0.0066
582 ISCHAEMIC STROKE 118 0.0066
583 MYOPATHY 57 0.0066
584 BLOOD CREATININE INCREASED 426 0.0065
585 BLOOD ALKALINE PHOSPHATASE INCREASED 161 0.0065
586 SQUAMOUS CELL CARCINOMA 61 0.0065
587 VENTRICULAR TACHYCARDIA 107 0.0065
588 HAEMOLYTIC ANAEMIA 58 0.0065
589 FACIAL PARALYSIS 55 0.0064
590 MYOCARDIAL ISCHAEMIA 73 0.0064
591 GASTROINTESTINAL DISORDER 572 0.0064
592 GENERALISED OEDEMA 79 0.0064
593 HYPOTENSION 1260 0.0063
594 PROTEINURIA 119 0.0063
595 RENAL FAILURE 827 0.0062
596 PULMONARY CONGESTION 82 0.0062
597 ABSCESS 99 0.0062
598 CORONAVIRUS INFECTION 41 0.0062
599 STATUS EPILEPTICUS 70 0.0062
600 RENAL IMPAIRMENT 520 0.0062
601 HEPATIC STEATOSIS 115 0.0062
602 SUBDURAL HAEMATOMA 88 0.0061
603 PULMONARY OEDEMA 275 0.0061
604 TOXIC EPIDERMAL NECROLYSIS 93 0.0061
605 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 435 0.0061
606 DIARRHOEA HAEMORRHAGIC 57 0.0061
607 GASTRIC HAEMORRHAGE 70 0.0061
608 CELLULITIS 305 0.0060
609 PYELONEPHRITIS 52 0.0060
610 HAEMATURIA 205 0.0060
611 ATAXIA 71 0.0060
612 ATRIOVENTRICULAR BLOCK COMPLETE 40 0.0060
613 EXPOSURE DURING PREGNANCY 370 0.0059
614 WHITE BLOOD CELL COUNT INCREASED 226 0.0059
615 GASTROINTESTINAL INFLAMMATION 46 0.0059
616 UPPER RESPIRATORY TRACT INFECTION 271 0.0059
617 TOXIC SKIN ERUPTION 59 0.0059
618 HEPATOCELLULAR INJURY 83 0.0058
619 URINE OUTPUT DECREASED 51 0.0058
620 TRANSFUSION 61 0.0058
621 ABDOMINAL PAIN 1349 0.0058
622 GASTRIC ULCER 110 0.0058
623 PULMONARY HYPERTENSION 120 0.0058
624 ELECTROCARDIOGRAM QT PROLONGED 207 0.0057
625 RENAL TUBULAR NECROSIS 56 0.0057
626 GENERALISED TONIC-CLONIC SEIZURE 94 0.0057
627 DERMATITIS 119 0.0057
628 APHTHOUS ULCER 44 0.0057
629 ORAL PAIN 127 0.0057
630 VOMITING 2644 0.0056
631 SUBARACHNOID HAEMORRHAGE 57 0.0056
632 PERICARDITIS 94 0.0056
633 BASAL CELL CARCINOMA 87 0.0056
634 RASH MACULO-PAPULAR 123 0.0055
635 CARDIOMEGALY 68 0.0055
636 SYNCOPE 544 0.0054
637 RED BLOOD CELL COUNT DECREASED 155 0.0054
638 GASTROINTESTINAL HAEMORRHAGE 453 0.0054
639 HYPERTHERMIA 41 0.0054
640 CONSTIPATION 1165 0.0053
641 RHINITIS 43 0.0053
642 LUNG DISORDER 261 0.0053
643 DEHYDRATION 709 0.0053
644 PERITONITIS 110 0.0053
645 BRAIN INJURY 53 0.0053
646 CARDIAC ARREST 433 0.0052
647 HICCUPS 42 0.0051
648 ASPIRATION 56 0.0051
649 INTESTINAL OBSTRUCTION 192 0.0051
650 DEAFNESS 133 0.0051
651 HAEMORRHOIDS 99 0.0051
652 THERAPEUTIC RESPONSE DECREASED 307 0.0051
653 NODULE 66 0.0051
654 DRUG INTOLERANCE 487 0.0050
655 CENTRAL NERVOUS SYSTEM LESION 69 0.0050
656 ORAL HERPES 98 0.0050
657 MOTOR DYSFUNCTION 51 0.0050
658 CIRCULATORY COLLAPSE 85 0.0050
659 TENDERNESS 52 0.0050
660 DECREASED APPETITE 1158 0.0050
661 VENTRICULAR FIBRILLATION 55 0.0049
662 DELIRIUM 171 0.0049
663 DECUBITUS ULCER 40 0.0049
664 CHILLS 572 0.0049
665 MENTAL STATUS CHANGES 135 0.0049
666 RESPIRATORY DISORDER 145 0.0048
667 METABOLIC ACIDOSIS 154 0.0048
668 RENAL FAILURE CHRONIC 37 0.0048
669 HYPOTONIA 48 0.0048
670 ILL-DEFINED DISORDER 292 0.0048
671 PNEUMONIA ASPIRATION 120 0.0048
672 FLANK PAIN 45 0.0048
673 JAUNDICE 129 0.0048
674 ANURIA 41 0.0048
675 HYPERKALAEMIA 167 0.0048
676 APNOEA 37 0.0047
677 GASTRITIS 125 0.0047
678 HYPOTHERMIA 48 0.0047
679 LIVER DISORDER 210 0.0047
680 BLOOD UREA INCREASED 79 0.0047
681 DYSPNOEA EXERTIONAL 176 0.0047
682 FLUID OVERLOAD 68 0.0047
683 NIGHT SWEATS 150 0.0047
684 DYSPHAGIA 437 0.0046
685 SPINAL COMPRESSION FRACTURE 38 0.0046
686 SKIN ULCER 118 0.0046
687 HYPERTHYROIDISM 66 0.0046
688 HYPOKINESIA 66 0.0045
689 CARDIAC FAILURE CONGESTIVE 359 0.0045
690 DRUG EXPOSURE DURING PREGNANCY 152 0.0045
691 POST PROCEDURAL HAEMORRHAGE 52 0.0045
692 SINUS BRADYCARDIA 43 0.0044
693 BLOOD CALCIUM INCREASED 39 0.0044
694 SUDDEN DEATH 47 0.0044
695 NO THERAPEUTIC RESPONSE 54 0.0044
696 ORTHOSTATIC HYPOTENSION 77 0.0044
697 VIRAL INFECTION 146 0.0044
698 MATERNAL EXPOSURE DURING PREGNANCY 389 0.0044
699 CEREBRAL INFARCTION 106 0.0043
700 ULCER 69 0.0043
701 MELAENA 95 0.0043
702 DIARRHOEA 2780 0.0043
703 GLOMERULAR FILTRATION RATE DECREASED 52 0.0042
704 DRUG LEVEL INCREASED 70 0.0042
705 THROMBOSIS 340 0.0042
706 WOUND INFECTION 46 0.0042
707 CYANOSIS 66 0.0042
708 CEREBRAL HAEMORRHAGE 150 0.0042
709 SKIN HYPERPIGMENTATION 36 0.0042
710 HAEMATEMESIS 106 0.0042
711 BLOOD CALCIUM DECREASED 47 0.0042
712 PRODUCT PRESCRIBING ISSUE 90 0.0041
713 ANAL INCONTINENCE 37 0.0041
714 PHARYNGITIS 51 0.0041
715 IMMUNE SYSTEM DISORDER 54 0.0041
716 NAUSEA 3232 0.0041
717 OEDEMA 221 0.0041
718 OSTEONECROSIS OF JAW 100 0.0040
719 BLOOD SODIUM DECREASED 76 0.0040
720 NEURALGIA 98 0.0040
721 DRUG INEFFECTIVE 5303 0.0040
722 HYPERLIPIDAEMIA 48 0.0040
723 SENSORY DISTURBANCE 64 0.0040
724 ASTHENIA 1496 0.0040
725 RED BLOOD CELL SEDIMENTATION RATE INCREASED 44 0.0040
726 PETECHIAE 41 0.0039
727 OBESITY 62 0.0039
728 AMENORRHOEA 68 0.0039
729 URINARY TRACT INFECTION 661 0.0039
730 PANCREATITIS 204 0.0039
731 DYSURIA 142 0.0039
732 FISTULA 43 0.0038
733 WEIGHT FLUCTUATION 40 0.0038
734 CARDIAC DISORDER 354 0.0038
735 VASCULITIS 44 0.0038
736 LIVER FUNCTION TEST INCREASED 81 0.0038
737 SEIZURE 433 0.0037
738 DIPLOPIA 97 0.0037
739 PLATELET COUNT INCREASED 48 0.0037
740 PALLOR 100 0.0037
741 ANAPHYLACTIC REACTION 203 0.0037
742 DEATH 3155 0.0037
743 EPILEPSY 111 0.0036
744 CARDIOVASCULAR DISORDER 92 0.0036
745 ACCIDENT 43 0.0036
746 BREAST PAIN 38 0.0036
747 RENAL FAILURE ACUTE 151 0.0036
748 CONDITION AGGRAVATED 1072 0.0035
749 BLINDNESS 143 0.0035
750 ALTERED STATE OF CONSCIOUSNESS 76 0.0035
751 OEDEMA PERIPHERAL 426 0.0035
752 DRUG INTERACTION 543 0.0034
753 BONE DISORDER 62 0.0034
754 COGNITIVE DISORDER 158 0.0034
755 OSTEOMYELITIS 61 0.0034
756 HYPERTENSION 713 0.0034
757 DYSPNOEA 1892 0.0033
758 TOOTH INFECTION 44 0.0033
759 PRESYNCOPE 81 0.0033
760 PRODUCTIVE COUGH 159 0.0033
761 ANGINA PECTORIS 95 0.0033
762 HEPATIC ENZYME INCREASED 226 0.0033
763 LACTIC ACIDOSIS 106 0.0033
764 BRADYCARDIA 173 0.0033
765 LOWER RESPIRATORY TRACT INFECTION 148 0.0033
766 OXYGEN SATURATION DECREASED 182 0.0032
767 CYSTITIS 103 0.0032
768 LIVER FUNCTION TEST ABNORMAL 94 0.0032
769 BLOOD POTASSIUM DECREASED 97 0.0032
770 EPISTAXIS 241 0.0032
771 MUSCLE TWITCHING 74 0.0032
772 HIP ARTHROPLASTY 49 0.0032
773 DEPRESSED LEVEL OF CONSCIOUSNESS 125 0.0032
774 INFLAMMATION 163 0.0032
775 COUGH 884 0.0031
776 BLOOD TEST ABNORMAL 44 0.0031
777 APHASIA 94 0.0031
778 SKIN DISORDER 103 0.0031
779 CONJUNCTIVITIS 57 0.0031
780 DIVERTICULITIS 85 0.0031
781 HIATUS HERNIA 39 0.0030
782 HAEMOPTYSIS 84 0.0030
783 LETHARGY 173 0.0030
784 PARALYSIS 43 0.0030
785 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 77 0.0030
786 ANAPHYLACTIC SHOCK 77 0.0030
787 MALIGNANT MELANOMA 40 0.0030
788 HEPATIC CIRRHOSIS 56 0.0030
789 DYSARTHRIA 112 0.0030
790 HAEMATOMA 77 0.0030
791 CARDIO-RESPIRATORY ARREST 124 0.0030
792 FATIGUE 2307 0.0030
793 SPINAL FRACTURE 59 0.0029
794 RECTAL HAEMORRHAGE 126 0.0029
795 ABDOMINAL PAIN LOWER 74 0.0029
796 WEIGHT DECREASED 814 0.0029
797 SARS-COV-2 TEST POSITIVE 38 0.0029
798 URINARY RETENTION 96 0.0029
799 BACK PAIN 665 0.0029
800 MUSCULOSKELETAL CHEST PAIN 44 0.0028
801 DRUG ERUPTION 50 0.0028
802 COMA 134 0.0028
803 DRUG EFFECT INCOMPLETE 102 0.0028
804 ANOREXIA 36 0.0028
805 SKIN REACTION 39 0.0028
806 CONFUSIONAL STATE 444 0.0027
807 BRONCHOSPASM 39 0.0027
808 UNRESPONSIVE TO STIMULI 69 0.0027
809 OSTEOPOROSIS 109 0.0026
810 DRUG TOXICITY 36 0.0026
811 COLON CANCER 39 0.0026
812 MUSCULAR WEAKNESS 295 0.0026
813 EMOTIONAL DISTRESS 313 0.0026
814 STEVENS-JOHNSON SYNDROME 57 0.0026
815 PULMONARY ARTERIAL HYPERTENSION 37 0.0026
816 HYPERSENSITIVITY 468 0.0025
817 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 73 0.0025
818 FULL BLOOD COUNT DECREASED 50 0.0025
819 HAEMATOCHEZIA 136 0.0025
820 HAEMORRHAGE 256 0.0024
821 DISORIENTATION 97 0.0024
822 OROPHARYNGEAL PAIN 226 0.0024
823 CHRONIC KIDNEY DISEASE 185 0.0024
824 MUSCULOSKELETAL DISORDER 46 0.0024
825 ADVERSE EVENT 221 0.0024
826 CHEST PAIN 430 0.0023
827 INCORRECT ROUTE OF DRUG ADMINISTRATION 82 0.0023
828 TASTE DISORDER 46 0.0023
829 BREAST CANCER 211 0.0023
830 RESTLESSNESS 82 0.0022
831 LUNG NEOPLASM MALIGNANT 92 0.0022
832 GOUT 40 0.0022
833 PSYCHOTIC DISORDER 65 0.0022
834 PARAESTHESIA 341 0.0022
835 ABDOMINAL DISTENSION 226 0.0022
836 INFLUENZA 241 0.0022
837 NEOPLASM MALIGNANT 141 0.0021
838 RASH ERYTHEMATOUS 100 0.0021
839 IMPAIRED HEALING 68 0.0021
840 CORONARY ARTERY DISEASE 62 0.0020
841 SKIN FISSURES 40 0.0020
842 SEROTONIN SYNDROME 39 0.0020
843 MYALGIA 345 0.0020
844 SPEECH DISORDER 106 0.0020
845 PAIN IN JAW 57 0.0020
846 FEMUR FRACTURE 62 0.0020
847 URINARY INCONTINENCE 59 0.0020
848 HYPOAESTHESIA 297 0.0020
849 RASH 865 0.0020
850 CHEST DISCOMFORT 203 0.0020
851 PELVIC PAIN 36 0.0020
852 RENAL INJURY 58 0.0020
853 BLOOD PRESSURE DECREASED 128 0.0019
854 GASTRIC CANCER 48 0.0019
855 INTERNATIONAL NORMALISED RATIO INCREASED 54 0.0019
856 ERYTHEMA 387 0.0019
857 EATING DISORDER 40 0.0019
858 TINNITUS 86 0.0019
859 PAIN 1127 0.0018
860 DYSPEPSIA 180 0.0018
861 FEEDING DISORDER 37 0.0018
862 LOSS OF CONSCIOUSNESS 228 0.0018
863 HALLUCINATION, VISUAL 37 0.0018
864 CHOLELITHIASIS 56 0.0017
865 DIABETES MELLITUS 129 0.0017
866 HYPOGLYCAEMIA 82 0.0017
867 CONTRAINDICATED PRODUCT ADMINISTERED 51 0.0017
868 MALAISE 733 0.0017
869 DIABETIC KETOACIDOSIS 40 0.0017
870 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 86 0.0016
871 PALPITATIONS 193 0.0016
872 DYSPHONIA 96 0.0016
873 SINUSITIS 167 0.0016
874 DISTURBANCE IN ATTENTION 87 0.0016
875 VISUAL ACUITY REDUCED 53 0.0016
876 BRONCHITIS 118 0.0016
877 RENAL DISORDER 74 0.0016
878 OESOPHAGEAL CARCINOMA 47 0.0016
879 POLLAKIURIA 66 0.0016
880 HYPERHIDROSIS 202 0.0016
881 ANXIETY 442 0.0016
882 TYPE 2 DIABETES MELLITUS 52 0.0015
883 MUSCULOSKELETAL PAIN 80 0.0015
884 RHINORRHOEA 97 0.0015
885 DYSGEUSIA 111 0.0015
886 BLOOD CREATINE PHOSPHOKINASE INCREASED 43 0.0015
887 CONVULSION 85 0.0015
888 ERECTILE DYSFUNCTION 38 0.0015
889 THERAPEUTIC PRODUCT EFFECT DECREASED 66 0.0015
890 HEADACHE 917 0.0015
891 MENTAL DISORDER 63 0.0014
892 PAIN IN EXTREMITY 418 0.0014
893 NECK PAIN 79 0.0014
894 MYOCARDIAL INFARCTION 243 0.0014
895 LACRIMATION INCREASED 42 0.0014
896 BLISTER 78 0.0014
897 DIZZINESS 687 0.0014
898 TRANSIENT ISCHAEMIC ATTACK 46 0.0014
899 ABDOMINAL PAIN UPPER 279 0.0014
900 AGITATION 99 0.0013
901 HEART RATE INCREASED 132 0.0013
902 HYPOACUSIS 57 0.0013
903 FLUSHING 131 0.0013
904 LABORATORY TEST ABNORMAL 38 0.0013
905 RHABDOMYOLYSIS 53 0.0013
906 NO ADVERSE EVENT 229 0.0013
907 ARTHRALGIA 524 0.0013
908 PRODUCT STORAGE ERROR 110 0.0013
909 DISCOMFORT 76 0.0012
910 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 42 0.0012
911 GASTROOESOPHAGEAL REFLUX DISEASE 100 0.0012
912 GAIT INABILITY 41 0.0012
913 ECZEMA 64 0.0012
914 WRONG TECHNIQUE IN DRUG USAGE PROCESS 44 0.0012
915 ADVERSE DRUG REACTION 108 0.0012
916 TREATMENT NONCOMPLIANCE 64 0.0012
917 RASH PRURITIC 63 0.0012
918 TREMOR 192 0.0012
919 SKIN DISCOLOURATION 53 0.0012
920 CEREBROVASCULAR ACCIDENT 195 0.0011
921 SKIN EXFOLIATION 96 0.0011
922 GAIT DISTURBANCE 217 0.0011
923 EYE DISORDER 37 0.0011
924 ABORTION SPONTANEOUS 45 0.0011
925 SOMNOLENCE 225 0.0011
926 SWELLING 104 0.0011
927 INFLUENZA LIKE ILLNESS 88 0.0011
928 DEPRESSED MOOD 56 0.0011
929 UNEVALUABLE EVENT 79 0.0010
930 VERTIGO 63 0.0010
931 DEPRESSION 235 0.0010
932 FALL 343 0.0010
933 BALANCE DISORDER 89 0.0010
934 PROSTATE CANCER 82 0.0010
935 DEVICE MALFUNCTION 70 0.0010
936 SLEEP DISORDER 70 0.0010
937 MEDICATION ERROR 55 0.0010
938 ARTHROPATHY 54 0.0010
939 FLUID RETENTION 49 0.0010
940 CATARACT 56 0.0009
941 FLATULENCE 53 0.0009
942 ABNORMAL BEHAVIOUR 37 0.0009
943 UNDERDOSE 68 0.0009
944 DRY MOUTH 75 0.0009
945 ABDOMINAL DISCOMFORT 154 0.0009
946 VISION BLURRED 124 0.0009
947 HOT FLUSH 68 0.0009
948 FEELING HOT 55 0.0009
949 ANGIOEDEMA 39 0.0009
950 DRY EYE 44 0.0009
951 MOBILITY DECREASED 63 0.0009
952 INSOMNIA 231 0.0009
953 PRURITUS 325 0.0008
954 AGGRESSION 42 0.0008
955 MEMORY IMPAIRMENT 115 0.0008
956 SWELLING FACE 54 0.0008
957 HALLUCINATION 60 0.0008
958 MIGRAINE 75 0.0008
959 WHEEZING 46 0.0008
960 PERIPHERAL SWELLING 119 0.0008
961 ARTHRITIS 60 0.0008
962 WEIGHT INCREASED 166 0.0007
963 VISUAL IMPAIRMENT 89 0.0007
964 URTICARIA 119 0.0007
965 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 128 0.0007
966 NASAL CONGESTION 41 0.0007
967 MUSCLE SPASMS 124 0.0007
968 BLOOD GLUCOSE INCREASED 123 0.0007
969 OVERDOSE 137 0.0006
970 BLOOD PRESSURE INCREASED 97 0.0006
971 IRRITABILITY 38 0.0006
972 BLADDER CANCER 37 0.0006
973 AMNESIA 40 0.0006
974 NASOPHARYNGITIS 113 0.0006
975 HOSPITALISATION 93 0.0006
976 CONTUSION 57 0.0006
977 INJURY 41 0.0006
978 ILLNESS 56 0.0005
979 ASTHMA 59 0.0005
980 MUSCULOSKELETAL STIFFNESS 41 0.0005
981 DRY SKIN 61 0.0005
982 JOINT SWELLING 41 0.0003
983 FEELING ABNORMAL 80 0.0003
984 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 65 0.0003
985 INCORRECT DOSE ADMINISTERED 41 0.0002
986 PRODUCT DOSE OMISSION ISSUE 43 0.0001
987 INJECTION SITE PAIN 39 0.0001